Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

News

Stay up to date on the latest crypto trends with our expert, in-depth coverage.

banner
Flash
21:27
According to the latest documents disclosed by the U.S. Securities and Exchange Commission (SEC), biotechnology company Q32 Bio Inc has officially signed an agreement to issue and sell approximately 1.7 million shares of common stock.
The pricing for this issuance is set at $3.90 per share, marking an important step in the company's capital operations. This transaction is expected to inject new capital into Q32 Bio Inc, supporting the advancement of its research pipeline and corporate operations.
News